Subgroup | Mafs | Cancer types | Key roles | Reference |
---|---|---|---|---|
Large Mafs | c-Maf | Multiple myeloma (MM) | c-Maf subgroup of MM is characterized by high proliferative index and is associated with cyclin D2 overexpression | [111] |
Stabilized by USP7 and USP5 and exerts anti-apoptosis effect on myeloma cells | ||||
Influences MM invasion process through regulating CXCL12 and ARK5 | ||||
Increases the interaction between tumor cells and stroma by increasing the expression of integrin β7 in MM | [115] | |||
Induces VEGF expression and promotes marrow neo-angiogenesis | [116] | |||
Lung cancer | Berbamine inhibited the migration and invasion abilities of non-small-cell lung cancer cells by downregulating c-Maf | [5] | ||
Facilitates tumor-associated macrophages polarization and promotes angiogenesis in NSCLC | [117] | |||
Breast cancer | Promotes breast cancer bone metastasis and may act as a biomarker of bone relapse | [118] | ||
MafA | MM | Stabilized by deubiquitinating enzyme USP7 and suppresses myeloma cell apoptosis | [11] | |
MafB | Colorectal cancer | Promotes colorectal cancer cell proliferation via regulating cell cycle and is correlated with advanced TNM stage | [103] | |
Liver cancer | Promotes HCC proliferation through enhancing Cyclin D1 | [119] | ||
Osteosarcoma | Drives cancer stemness in osteosarcoma. High MafB expression is strongly correlated with poor prognosis | [120] | ||
Ovarian cancer | Promotes the proliferation and invasion of ovarian cancer cells and reduces olaparib/cisplatin sensitivity | [121] | ||
NRL | Medulloblastoma | Protects cells from apoptosis and mediates cell cycle progression | [122] | |
Small Mafs | MafG | Colorectal cancer | Differentially expressed between highly metastatic colorectal cancer and nonmetastatic colorectal cancer | [123] |
Enhances proliferation by heterodimerizing with Bach1 and recruiting CHD8 and DNMT3B | [124] | |||
Liver cancer | Promotes proliferation through heterodimerizing with Nrf2 or interacting with c-Myc and c-Maf | |||
Lung cancer | Accelerates cell proliferation and inhibits cell apoptosis in lung adenocarcinoma | [71] | ||
MafK | Breast cancer | Induces EMT and promotes tumor invasion in vivo | [126] | |
MafF | Liver cancer | Drives liver tumor-initiating cells metastasis and antagonizes the retinoid-mediated suppression of HCC invasion | ||
Breast cancer | Promotes tumor invasion through heterodimerizing with Bach1 and activating IL11/STAT3 pathway | [128] |